Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Castagnola

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Frontiers in Synaptic Neuroscience|November 23, 2017
The Search for an Effective Therapy to Treat Fragile X Syndrome: Dream or Reality?Sara Castagnola, Barbara Bardoni, Thomas Maurin
Nucleic Acids Research|April 19, 2018
HITS-CLIP in various brain areas reveals new targets and new modalities of RNA binding by fragile X mental retardation proteinThomas Maurin, Kevin Lebrigand, Sara Castagnola, et al.
Genome Research|September 25, 2020
Agonist-induced functional analysis and cell sorting associated with single-cell transcriptomics characterizes cell subtypes in normal and pathological brainSara Castagnola, Julie Cazareth, Kevin Lebrigand, et al.
Molecular Therapy. Nucleic Acids|November 1, 2019
Reduction of Fmr1 mRNA Levels Rescues Pathological Features in Cortical Neurons in a Model of FXTASMalgorzata Drozd, Sébastien Delhaye, Thomas Maurin, et al.
Frontiers in Molecular Neuroscience|October 16, 2018
New Insights Into the Role of Ca<sub>v</sub>2 Protein Family in Calcium Flux Deregulation in <i>Fmr1</i>-KO NeuronsSara Castagnola, Sébastien Delhaye, Alessandra Folci, et al.
Nature Communications|February 24, 2018
Sumoylation regulates FMRP-mediated dendritic spine elimination and maturationAnouar Khayachi, Carole Gwizdek, Gwénola Poupon, et al.
Cerebral Cortex (New York, N.Y. : 1991)|August 24, 2018
Involvement of Phosphodiesterase 2A Activity in the Pathophysiology of Fragile X SyndromeThomas Maurin, Francesca Melancia, Marielle Jarjat, et al.
Nature Communications|March 11, 2021
Missense mutation of Fmr1 results in impaired AMPAR-mediated plasticity and socio-cognitive deficits in miceMarta Prieto, Alessandra Folci, Gwénola Poupon, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Frontiers in Synaptic Neuroscience|November 23, 2017
The Search for an Effective Therapy to Treat Fragile X Syndrome: Dream or Reality?Sara Castagnola, Barbara Bardoni, Thomas Maurin
Nucleic Acids Research|April 19, 2018
HITS-CLIP in various brain areas reveals new targets and new modalities of RNA binding by fragile X mental retardation proteinThomas Maurin, Kevin Lebrigand, Sara Castagnola, et al.
Genome Research|September 25, 2020
Agonist-induced functional analysis and cell sorting associated with single-cell transcriptomics characterizes cell subtypes in normal and pathological brainSara Castagnola, Julie Cazareth, Kevin Lebrigand, et al.
Molecular Therapy. Nucleic Acids|November 1, 2019
Reduction of Fmr1 mRNA Levels Rescues Pathological Features in Cortical Neurons in a Model of FXTASMalgorzata Drozd, Sébastien Delhaye, Thomas Maurin, et al.
Frontiers in Molecular Neuroscience|October 16, 2018
New Insights Into the Role of Ca<sub>v</sub>2 Protein Family in Calcium Flux Deregulation in <i>Fmr1</i>-KO NeuronsSara Castagnola, Sébastien Delhaye, Alessandra Folci, et al.
Nature Communications|February 24, 2018
Sumoylation regulates FMRP-mediated dendritic spine elimination and maturationAnouar Khayachi, Carole Gwizdek, Gwénola Poupon, et al.
Cerebral Cortex (New York, N.Y. : 1991)|August 24, 2018
Involvement of Phosphodiesterase 2A Activity in the Pathophysiology of Fragile X SyndromeThomas Maurin, Francesca Melancia, Marielle Jarjat, et al.
Nature Communications|March 11, 2021
Missense mutation of Fmr1 results in impaired AMPAR-mediated plasticity and socio-cognitive deficits in miceMarta Prieto, Alessandra Folci, Gwénola Poupon, et al.
Pageof 1